BIB · ProShares Ultra Nasdaq Biotechnology ETF
ProShares Trust
$117.41
-4.65%
At close · Nov 12
Net assets $101,351,690
Holdings264
1 month
+5.67%
Year to date
+47.18%
52-week range
$73.12–$126.40
30-session avg volume
8,910
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000018718
- Report date
- Aug 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings50.88%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC54.37%
RA22.21%
DE11.76%
STIV0.54%
Country allocation
US85.98%
NL1.30%
GB1.26%
IE0.91%
BM0.88%
DK0.66%
CH0.62%
Other2.20%
Portfolio holdings
Latest linked SEC Form NPORT-P report. Pull holdings through the ETF holdings API or MCP →
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Repurchase Agreement | 000000000 | $9,343,385 | 9.22% |
| Repurchase Agreement | 000000000 | $6,212,617 | 6.13% |
| $5,641,993 | 5.57% | ||
| $5,277,334 | 5.21% | ||
| ProShares GENIUS Money Market ETF | 74350P691 | $5,006,000 | 4.94% |
| Amgen, Inc. | AMGN | $4,782,415 | 4.72% |
| Vertex Pharmaceuticals, Inc. | VRTX | $4,560,355 | 4.50% |
| Gilead Sciences, Inc. | GILD | $4,079,374 | 4.02% |
| Repurchase Agreement | 000000000 | $3,727,570 | 3.68% |
| Regeneron Pharmaceuticals, Inc. | REGN | $2,941,413 | 2.90% |
| Moderna, Inc. | MRNA | $1,991,144 | 1.96% |
| Repurchase Agreement | 000000000 | $1,988,037 | 1.96% |
| Revolution Medicines, Inc. | RVMD | $1,561,715 | 1.54% |
| Repurchase Agreement | 000000000 | $1,242,523 | 1.23% |
| Illumina, Inc. | ILMN | $1,155,525 | 1.14% |
| Alnylam Pharmaceuticals, Inc. | ALNY | $1,148,332 | 1.13% |
| Biogen, Inc. | BIIB | $1,143,262 | 1.13% |
| Argenx SE | ARGX | $1,019,280 | 1.01% |
| Royalty Pharma plc | $973,349 | 0.96% | |
| $964,150 | 0.95% | ||
| Insmed, Inc. | INSM | $943,983 | 0.93% |
| Roivant Sciences Ltd. | $890,560 | 0.88% | |
| Incyte Corp. | INCY | $879,914 | 0.87% |
| United Therapeutics Corp. | UTHR | $774,246 | 0.76% |
| Guardant Health, Inc. | GH | $753,755 | 0.74% |
| Viatris, Inc. | VTRS | $687,212 | 0.68% |
| $681,565 | 0.67% | ||
| Medpace Holdings, Inc. | MEDP | $604,682 | 0.60% |
| Ascendis Pharma A/S | $579,214 | 0.57% | |
| Jazz Pharmaceuticals plc | $562,025 | 0.55% | |
| Neurocrine Biosciences, Inc. | NBIX | $553,738 | 0.55% |
| INVESCO GOVT AND AGCY LEX | 825252885 | $542,617 | 0.54% |
| Bridgebio Pharma, Inc. | BBIO | $535,977 | 0.53% |
| Exelixis, Inc. | EXEL | $490,940 | 0.48% |
| Halozyme Therapeutics, Inc. | HALO | $451,305 | 0.45% |
| BioMarin Pharmaceutical, Inc. | BMRN | $450,478 | 0.44% |
| Madrigal Pharmaceuticals, Inc. | MDGL | $445,525 | 0.44% |
| BeOne Medicines Ltd. | ONC | $423,585 | 0.42% |
| BioNTech SE | BNTX | $422,291 | 0.42% |
| $415,756 | 0.41% | ||
| Arrowhead Pharmaceuticals, Inc. | ARWR | $414,586 | 0.41% |
| Tempus AI, Inc. | TEM | $393,117 | 0.39% |
| Krystal Biotech, Inc. | KRYS | $379,484 | 0.37% |
| Summit Therapeutics, Inc. | SMMT | $377,832 | 0.37% |
| Sanofi SA | SNY | $368,853 | 0.36% |
| Axsome Therapeutics, Inc. | AXSM | $364,880 | 0.36% |
| Ionis Pharmaceuticals, Inc. | IONS | $356,426 | 0.35% |
| Praxis Precision Medicines, Inc. | PRAX | $349,950 | 0.35% |
| Kymera Therapeutics, Inc. | KYMR | $349,539 | 0.34% |
| Cytokinetics, Inc. | CYTK | $343,701 | 0.34% |
Showing the top 50 of 264 holdings. Create a free account to see every holding and download the CSV.